BIOXYTRAN, INC (56)
Browse by Contract Category
Contracts
-
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $64,900 dated March 18, 2020
(Filed With SEC on March 26, 2020)
-
Form of Letter Agreement between FON Consulting, LLC and Bioxytran, Inc. dated November 11, 2019
(Filed With SEC on November 12, 2019)
-
Form of Advisory Board Agreement between Bioxytran, Inc. and Patrick Huddie dated September 13, 2019
(Filed With SEC on September 13, 2019)
-
Investor Relations Agreement between Bioxytran, Inc. and Resources Unlimited NW LLC. dated April 22, 2019
(Filed With SEC on April 26, 2019)
-
License Agreement between Bioxytran, Inc. and MDX Lifesciences, Inc. dated April 4, 2019
(Filed With SEC on April 5, 2019)
-
Securities Purchase Agreement between Power Up Lending Group LLC and Bioxytran, Inc., dated March 18, 2020
(Filed With SEC on March 26, 2020)
-
Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated February 25, 2019
(Filed With SEC on March 12, 2020)
-
Amendment #1 to Securities Purchase Agreement between Auctus Fund LLC and Bioxytran, Inc., dated October 24, 2018
(Filed With SEC on March 12, 2020)
-
Warrant to Purchase 22,000 shares of Common Stock of Bioxytran
(Filed With SEC on February 26, 2020)
-
4% Convertible Note of Bioxytran, Inc. to Crown Bridge Partners, LLC in the Principal Amount of $55,000 dated October 30, 2019
(Filed With SEC on February 26, 2020)
-
Securities Purchase Agreement between Crown Bridge Partners, LLC and Bioxytran, Inc., dated October 30, 2019
(Filed With SEC on February 26, 2020)
-
8% Convertible Debenture of Bioxytran, Inc. to Power Up Lending Group LLC in the Principal Amount of $56,600 dated January 18, 2020
(Filed With SEC on February 26, 2020)
-
Securities Purchase Agreement between Power Up Lending Group LLC and Bioxytran, Inc., dated January 18, 2020
(Filed With SEC on February 26, 2020)
-
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on January 15, 2020)
-
4% Convertible Note of Bioxytran, Inc. to EMA Financial LLC. in the Principal Amount of $125,000 dated January 10, 2020
(Filed With SEC on January 15, 2020)
-
Securities Purchase Agreement between EMA Financial LLC and Bioxytran, Inc., dated January 10, 2020
(Filed With SEC on January 15, 2020)
-
8% Convertible Note of Bioxytran, Inc. to Power Up Lending Group in the Principal Amount of $54,600 dated December 30, 2019
(Filed With SEC on January 6, 2020)
-
Securities Purchase Agreement between Power Up Lending Group and Bioxytran, Inc., dated December 30, 2019
(Filed With SEC on January 6, 2020)
-
Securities Purchase Agreement between FirstFire Global Opportunities Fund, LLC and Bioxytran, Inc., dated November 20, 2019
(Filed With SEC on November 25, 2019)
-
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on November 25, 2019)
-
4% Convertible Note of Bioxytran, Inc. to FirstFire Global Opportunities Fund, LLC. in the Principal Amount of $125,000 dated November 20, 2019
(Filed With SEC on November 25, 2019)
-
Form of Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on November 12, 2019)
-
Form of 4% Convertible Note of Bioxytran, Inc. to GS Capital Partners, LLC. in the Principal Amount of $125,000 dated November 7, 2019
(Filed With SEC on November 12, 2019)
-
Form of Securities Purchase Agreement between GS Capital Partners, LLC and Bioxytran, Inc., dated No ember 7, 2019
(Filed With SEC on November 12, 2019)
-
Securities Purchase Agreement between Peak One Opportunity Fund, L.P. and Bioxytran, Inc., dated October 22, 2019
(Filed With SEC on November 5, 2019)
-
Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019
(Filed With SEC on November 5, 2019)
-
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on November 5, 2019)
-
8% Convertible Note of Bioxytran, Inc. to Tangiers Global, LLC in the Principal Amount of $106,300 dated October 23, 2019
(Filed With SEC on November 5, 2019)
-
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on November 5, 2019)
-
Securities Purchase Agreement between PowerUp Lending Group Ltd. and Bioxytran, Inc., dated October 21, 2019
(Filed With SEC on November 5, 2019)
-
8% Convertible Note of Bioxytran, Inc. to PowerUp Lending Group Ltd. in the Principal Amount of $106,000 dated October 21, 2019
(Filed With SEC on November 5, 2019)
-
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on October 28, 2019)
-
8% Convertible Note of Bioxytran, Inc. to PowerUp Lending Group Ltd. in the Principal Amount of $106,000 dated October 21, 2019
(Filed With SEC on October 28, 2019)
-
Securities Purchase Agreement between PowerUp Lending Group Ltd. and Bioxytran, Inc., dated October 21, 2019
(Filed With SEC on October 28, 2019)
-
Securities Purchase Agreement between Peak One Opportunity Fund, L.P. and Bioxytran, Inc., dated October 22, 2019
(Filed With SEC on October 28, 2019)
-
8% Convertible Note of Bioxytran, Inc. to Tangiers Global, LLC in the Principal Amount of $106,300 dated October 23, 2019
(Filed With SEC on October 28, 2019)
-
8% Convertible Debenture of Bioxytran, Inc. to Peak One Opportunity Fund, L.P. in the Principal Amount of $120,000 dated October 22, 2019
(Filed With SEC on October 28, 2019)
-
Warrant to Purchase 50,000 shares of Common Stock of Bioxytran
(Filed With SEC on October 28, 2019)
-
Form of Advisory Board Agreement between Bioxytran, Inc. and Jonathan Jensen Dated September 13, 2019
(Filed With SEC on September 13, 2019)
-
Form of Advisory Board Agreement between Bioxytran, Inc. and Cynthia Tsai effective July 16, 2019
(Filed With SEC on August 1, 2019)
-
Form of Advisory Board Agreement between Bioxytran, Inc. and Jonathan Barkman effective July 15, 2019
(Filed With SEC on August 1, 2019)
-
Form of Advisory Board Agreement between Bioxytran, Inc. and Steven Aust dated June 11, 2019
(Filed With SEC on June 12, 2019)
-
Scientific Advisory Board Agreement between Bioxytran, Inc. and Asclepius LLC dated May 1, 2019
(Filed With SEC on May 6, 2019)
-
Form of Securities Purchase Agreement between U.S. Rare Earth Minerals, Inc. and Auctus Fund, LLC, dated February 25, 2019
(Filed With SEC on March 1, 2019)
-
Form of Warrant of dated February 25, 2019
(Filed With SEC on March 1, 2019)
-
Form of Registration Rights Agreement between U.S. Rare Earth Minerals, Inc. and Auctus Fund, LLC, dated February 25, 2019
(Filed With SEC on March 1, 2019)
-
Form of $250,000 Senior Secured Promissory Note, dated February 25, 2019, of U.S. Rare Earth Minerals, Inc. and Auctus Fund, LLC, dated February 25, 2019
(Filed With SEC on March 1, 2019)
-
Form of Security Agreement dated February 25, 2019, between U.S. Rare Earth Minerals, Inc., and Auctus Fund, LLC, dated February 25, 2019
(Filed With SEC on March 1, 2019)
-
Form of Common Stock Certificate
(Filed With SEC on February 1, 2019)
-
Form of Employment Agreement of David Platt
(Filed With SEC on February 1, 2019)
-
Form of Employment Agreement of Ola Soderquist
(Filed With SEC on February 1, 2019)
-
Form of Public Offering Subscription Agreement
(Filed With SEC on February 1, 2019)
-
Form of Public Offering Subscription Agreement
(Filed With SEC on January 30, 2019)
-
Form of Employment Agreement of Ola Soderquist
(Filed With SEC on January 30, 2019)
-
Form of Employment Agreement of David Platt
(Filed With SEC on January 30, 2019)
-
Form of Common Stock Certificate
(Filed With SEC on January 30, 2019)